On 18 September 2020, the Commission announced that it will support with €15.7 million an ambitious new research initiative, EU-RESPONSE, which will establish a clinical research network to treat COVID-19 and other emerging infectious diseases. The funding is part of the Commission's €1.4 billion pledge, from which €1 billion come from Horizon 2020, for coronavirus research and innovation directed towards the development of vaccines, new treatments and diagnostic tools to prevent the spread of the virus.
The EU-RESPONSE consortium, led by the Institut National de la Santé et de la Recherche Médicale (INSERM), brings together 21 partners with world-class research capabilities from 13 EU countries, Norway, Switzerland and Turkey. The project adds to the portfolio of EU-funded research and innovation actions and complements the public health policy and activities that the Commission is coordinating with the Member States.
For more information: